Compare Evagene against every major clinical pedigree platform
Honest, source-bound, side-by-side comparisons. Every claim about another product is drawn from that product's public website as of April 2026. Where a competitor is stronger, we say so.
How we compare
Feature matrices compiled from public product pages and documentation. A tick means the capability is publicly advertised or documented; a dash means it is not publicly listed (which does not necessarily mean it is absent — enterprise products often keep capabilities behind sales). We do not invent pricing, customer counts, or feature claims. Under UK Trade Marks Act 1994 s.10(6) and the Business Protection from Misleading Marketing Regulations 2008, honest comparative advertising is protected; misleading claims are not. We aim for the former.
What distinguishes Evagene across this comparison set
The functional distinction that shows up most often in these comparisons is breadth of risk modelling on a single pedigree. Evagene now covers four families of risk model — Mendelian single-gene, polygenic / oligogenic / multifactorial liability-threshold, cancer family-history scoring (BRCAPRO, MMRpro, PancPRO, Claus, Couch, Frank, Manchester, NICE CG164/NG101, Amsterdam II, revised Bethesda, Gail NCI BCRAT, and a Tyrer-Cuzick IBIS-style approximation), and a one-click CanRisk / BOADICEA pedigree export — from the same pedigree document with no re-keying. Among the products compared here, Phenotips, Progeny, and TrakGene focus on the clinical-record layer; FamGenix and CanRisk focus on cancer-risk scoring; QuickPed and GenoPro focus on drawing and relatedness.
Two boundaries to call out in every comparison:
- Tyrer-Cuzick is an approximation of the published 2004 algorithm, not the official IBIS Breast Cancer Risk Evaluator binary. Evagene's UI labels this explicitly.
- BOADICEA is not bundled. Evagene exports a
##CanRisk 2.0pedigree file the clinician uploads at canrisk.org — the legally clean path to the University of Cambridge-licensed gold-standard tool.
For the per-model indications, see the decision matrix for clinical geneticists. For the polygenic / multifactorial catalogue, see complex-disease pedigree software. For the full release notes, see the April 2026 risk-engine expansion.
Direct clinical competitors
Newer and academic competitors
Cross-competitor comparisons (without Evagene upfront)
Sometimes you want to see how two competitors stack up against each other, without us steering you to ourselves. These pages lead with the head-to-head and mention Evagene only at the end.
Generic diagramming tools repurposed for pedigrees
These are general diagram makers with pedigree templates. They draw circles and squares. They don't enforce clinical notation, run risk models, or integrate with health systems — but many searchers end up on them by accident. These pages explain what they do and don't cover.
Migration guides
Looking for something else?
If you're not sure which product is yours to compare against, try one of these field guides.